Molecular Detection says it will launch MRSA test next year

06/25/2010 | GenomeWeb Daily News (free registration)

Molecular Detection said it will likely launch its Detect-Ready MRSA test in the U.S. in the first half of next year. The test can identify the bacteria in nasal swab samples. The company said it also is developing tests for C. difficile and vancomycin-resistant enterococcus, and a variation of the MRSA test that will use blood samples.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD